Search Results - "Koutsovasilis, Anastasios"

Refine Results
  1. 1
  2. 2

    Measurement of mean systemic filling pressure after severe hemorrhagic shock in swine anesthetized with propofol-based total intravenous anesthesia: implications for vasopressor-free resuscitation by Chalkias, Athanasios, Koutsovasilis, Anastasios, Laou, Eleni, Papalois, Apostolos, Xanthos, Theodoros

    Published in Acute and critical care (01-05-2020)
    “…BACKGROUNDMean systemic filling pressure (Pmsf) is a quantitative measurement of a patient's volume status and represents the tone of the venous reservoir. The…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Clinical audit as a tool to optimize contracted private healthcare provision: Testing the waters in resource-deprived Greece by Souliotis, Kyriakos, Golna, Christina, Mantzana, Vasiliki, Papaspyropoulos, Sotirios, Koutsovasilis, Anastasios, Sotiropoulos, Alexios

    Published in SAGE open medicine (2019)
    “…Background and Aims: Clinical audit is applied to optimize clinical practice and quality of healthcare services while controlling for money spent, critically…”
    Get full text
    Journal Article
  5. 5

    Activated charcoal may not be necessary in all oral overdoses of medication by Orfanidou, Georgia, RN, Chalkias, Athanasios, PhD, Koutsovasilis, Anastasios, MSc, Loizos, Georgios, MD, Xanthos, Theodoros, PhD

    Published in The American journal of emergency medicine (01-02-2016)
    “…[...]384 subjects (66%), 374 (97.4%) as suicide attempts and 10 (2.6%) as accidental overdoses, were included in our study…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    968-P: Long-Term Quantitative and Qualitative Effect of Dulaglutide in Type 2 Diabetes Patients by KOUTSOVASILIS, ANASTASIOS, SOTIROPOULOS, ALEXIOS, PAPPA, MARIA, PEPPAS, THEODOROS

    Published in Diabetes (New York, N.Y.) (01-06-2020)
    “…Background: Dulaglutide is a once-weekly glucagon-like peptide-1 receptor agonist GLP-1. Aim: The aim of the study was to investigate dulaglutide’s…”
    Get full text
    Journal Article
  12. 12

    2196-PUB: The Influence of Insulin Degludec on Type 2 Diabetes Mellitus Regulation and Patient Quality of Life Compared with Insulin Glargine in Low-Income Patients by KOUTSOVASILIS, ANASTASIOS, SOTIROPOULOS, ALEXIOS, PAPPA, MARIA, BOUSBOULAS, STAVROS, PEPPAS, THEODOROS

    Published in Diabetes (New York, N.Y.) (01-06-2020)
    “…Background: Insulin glargine is a well known long-acting insulin analog in the contemporary treatment of type 2 diabetes mellitus (T2DM). A new long-acting,…”
    Get full text
    Journal Article
  13. 13

    1022-P: Quantitative and Qualitative Effect of Dulaglutide in Type 2 Diabetes Patients Under Treatment with Liraglutide by SOTIROPOULOS, ALEXIOS, KOUTSOVASILIS, ANASTASIOS, ANTONIOU, ANASTASIA, BOUSBOULAS, STAVROS, PEPPAS, THEODOROS

    Published in Diabetes (New York, N.Y.) (01-06-2019)
    “…Background: Liraglutide and dulaglutide are long-acting GLP-1 receptor agonists. Dulaglutide is used once a week, while liraglutide once a day. Aim: The aim of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Airway pressure and outcome of out-of-hospital cardiac arrest: A prospective observational study by Chalkias, Athanasios, Pavlopoulos, Fotios, Koutsovasilis, Anastasios, d'Aloja, Ernesto, Xanthos, Theodoros

    Published in Resuscitation (01-01-2017)
    “…Abstract AIM To assess the usefulness of airway pressure as predictor of return of spontaneous circulation (ROSC), as well as to investigate the optimized…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    1065-P: The Effect of a Closed-Loop Insulin Delivery System on Glycemic Control in Type 1 Diabetes by KOUTSOVASILIS, ANASTASIOS, SOTIROPOULOS, ALEXIOS, ANTONIOU, ANASTASIA, KORDINAS, VASILIOS, PAPADAKI, DESPINA, PEPPAS, THEODOROS

    Published in Diabetes (New York, N.Y.) (01-06-2019)
    “…Background: Using a software, which creates a closed loop between the pump and the monitoring glucose sensor is considered to be a progress in controlling and…”
    Get full text
    Journal Article
  19. 19

    1111-P: The Qualitative and Quantitative Effect of IDegLira Compared with the Nonfixed Administration of Degludec and Liraglutide by KOUTSOVASILIS, ANASTASIOS, SOTIROPOULOS, ALEXIOS, ANTONIOU, ANASTASIA, PAPPA, MARIA, BOUSBOULAS, STAVROS, PEPPAS, THEODOROS

    Published in Diabetes (New York, N.Y.) (01-06-2019)
    “…Background: The efficacy and safety of IDegLira and the benefits of its complementary mode of action have been examined in the large global DUAL clinical trial…”
    Get full text
    Journal Article
  20. 20